Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00063570
Status:
COMPLETED
Last Update Posted:
2009-05-29
First Post:
2003-06-30
Brief Title:
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company